Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Research
[키워드] Admission
age
Aggressive
analyzed
Angiotensin-converting enzyme
Arrhythmias
association
blocker
Cardiomyopathy
cardiovascular
cardiovascular disease
case sery
change
China
city
collected
Comorbidities
confirmed case
Coronary heart disease
coronavirus disease
country
COVID-19
CVD
death
demographic
demonstrated
died
discharged
dysfunction
elevated
evaluate
Evidence
exhibited
finding
glucocorticoid
had more
high risk
High-sensitivity C-reactive protein
Hospitalization
hypertension
Importance
Increasing
indicated
Injury
Laboratory
measure
mechanical ventilation
median
Mortality
mortality rate
myocardial injury
N-terminal
NT-proBNP
objective
outcome
participant
Patient
patients with COVID-19
peptide
plasma
Point
positive linear correlation
potential mechanism
prognosis of patient
receptor
Relevance
Result
retrospective
setting
significantly
single-center
survivor
the patient
therapy
TnT level
TnT levels
Treatment
Wuhan
[DOI] 10.1001/jamacardio.2020.1017 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamacardio.2020.1017 PMC 바로가기 [Article Type] Research